FDA Drug Safety Oversight Board Will Include VA, Other Agencies
This article was originally published in The Pink Sheet Daily
Executive Summary
The panel is the primary feature of FDA's proposal to reform drug safety review within the agency; other features include the creation of a drug safety website. The panel and website are intended to increase drug safety "oversight" and "openness" at FDA.